Page last updated: 2024-10-30

leflunomide and Uveitis, Anterior

leflunomide has been researched along with Uveitis, Anterior in 2 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Uveitis, Anterior: Inflammation of the anterior uvea comprising the iris, angle structures, and the ciliary body. Manifestations of this disorder include ciliary injection, exudation into the anterior chamber, iris changes, and adhesions between the iris and lens (posterior synechiae). Intraocular pressure may be increased or reduced.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Molina, C1
Modesto, C1
Martín-Begué, N1
Arnal, C1
Roy, M1

Other Studies

2 other studies available for leflunomide and Uveitis, Anterior

ArticleYear
Leflunomide, a valid and safe drug for the treatment of chronic anterior uveitis associated with juvenile idiopathic arthritis.
    Clinical rheumatology, 2013, Volume: 32, Issue:11

    Topics: Adolescent; Adult; Antirheumatic Agents; Arthritis, Juvenile; Child; Chronic Disease; Female; Humans

2013
Early clinical experience with leflunomide in uveitis.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2007, Volume: 42, Issue:4

    Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Humans; Immunosuppressive Agen

2007